Lanx is a Broomfield, CO-based global spine company that develops and commercializes a line of fusion devices and minimally invasive technologies. The company closed a $15M Series C equity financing to support growth. It plans to use the funds to increase its sales and marketing infrastructure and to expand its product suite across both minimally invasive and core spinal fusion. Led by CEO Dan Gladney, Lanx’s platform includes minimally invasive technologies and a range of fusion solutions. Product examples cited include the TIMBERLINE™ Lateral Fusion System and the ASPEN® MIS Fusion System. Lanx distributes its portfolio throughout the U.S., Mexico and Europe via a network of direct sales representatives and exclusive distributor partners.

Total raised

$15M

Funding rounds

1

Latest round

Series C

Latest activity

May 2013